COVID-19 UK variant mutates again and may be able to evade vaccines and immune system

The contagious COVID-19 strain has mutated again and may now be more resistant to antibodies, scientists warned amid a new testing blitz.

The contagious UK variant of COVID-19 has mutated again, in worrying genetic changes that may give the virus the ability to evade the immune system, according to scientists.

Public Health England reported that tests on some samples detected genomes with the E484K mutation, which has already been seen in the highly transmissible South African and Brazilian variants.

Calum Semple, a top scientist advising the UK government, told the BBC radio that this “mutation of most concern” had developed spontaneously in the UK variant first detected in Kent in England’s south.

“The mutation of most concern, which we call E484K, has also occurred spontaneously in the new Kent strain in parts of the country too,” said Professor Semple, a member of the Scientific Advisory Group for Emergencies (SAGE).

RELATED: Fears as South African strain spreads

Police volunteers are helping to distribute COVID-19 testing kits to all residents in Woking, southwest of London, as authorities launch a blitz on the South African mutation. Picture: Adrian Dennis / AFP

RELATED: Major blow for Aussies in COVID bombshell

Sky’s science correspondent Thomas Moore said the “worrying development” meant the virus had effectively “developed a superpower” which enabled it to not only infect cells, but also to evade the immune system.

Research suggests the mutation may be more resistant to antibodies, although Moderna and Pfizer have claimed their vaccines are still effective.

Early testing by Moderna found that its vaccine could protect against the mutation, although the effects may not be as strong or last as long. AstraZeneca is due to announce results on its vaccine effectiveness against the mutation this week.

UK Health Secretary Matt Hancock on Tuesday said a further 11 cases of mutations of concern had been identified in Bristol and 32 in Liverpool, warning of “renewed challenges posed by new variants of the coronavirus”.

RELATED: Fears as South African COVID-19 strain spreads

Health officials warned the UK variant has mutated again, and may now be able to evade the immune system. Picture: Adrian Dennis / AFP

At least 105 cases of the variant first identified in South Africa have already emerged in the UK, including 11 with no links to international travel, in parts of London, the West Midlands,

East, South East and North West England.

Authorities in these areas have starting offering door-to-door and mobile testing as part of a push to test 80,000 people for the variant, and are sequencing of every positive test.

“In all these areas it is imperative that people must stay at home and only leave home where it is absolutely essential,” Mr Hancock said.

The government is offered testing to everyone in these areas aged over 16, even if they have had the vaccine. Mr Hancock urged all residents and everyone who has to leave home for essential work to get tested.

Workplace testing is also being expanded across the country, including at the UK parliament, and “more scientific work is underway to leaven more about new variants”, the Health Secretary added.

He said “the message is more important than ever to stay at home, maintain social distancing and get tested.”

The UK government is urgently increasing testing across England to battle the E484K ‘mutation of most concern’. Picture: Adrian Dennis / AFP

The UK has now vaccinated 9.2 million people, including a million in one weekend, he reported.

“We must all keep at it, we’ve sacrificed so much,” he added, warning of “difficult weeks ahead”.

The UK is ahead of many countries in the vaccine race, and has now given shots to 13.7 per cent of its population, compared with the US at 32.2 million or 7.9 per cent.

Israel leads the pack, with 37 per cent of its population having received at least one dose, while more than a fifth have already had a second.

But the European Union commission chief defended the slower COVID-19 vaccine in the EU, telling French newspaper Le Monde: “The commission and the member states agreed not to compromise on the safety and effectiveness requirements linked to the authorisation of a vaccine.”